A People-First Philosophy Led Jeffrey Johnson to Success in Spine
U.S. Hospitals Balance COVID Response with Long-Term Outlook
What Does the Next Generation of Total Ankles Need?
Preoperative planning, surgical instrumentation and bony ingrowth are advancements that surgeon Alan Davis, M.D., says are a must for future total ankles.
Medacta CEO Confident in Orthopedics’ Fundamentals
Mr. Francesco Siccardi opens up about market opportunities, headwinds and strategies for Medacta while dealing with the COVID-19 outbreak.
COVID-19 Amplifies Focus on the Cost of Care
In this video, trauma surgeon Peter Althausen, M.D., says COVID-19 will shift procedures to outpatient settings and place scrutiny on implant utilization.
COVID-19 is a Disruption Accelerator. Are You Prepared?
Tiger Buford talks about changes to technology and the roles of product development and sales and marketing post-COVID-19.
Retiring Bioventus CEO Shares Thoughts on Orthobiologics Market
What Will 1Q20 Earnings Tell Us about a COVID-19 Recovery?
First-quarter earnings announcements start in earnest today. We think a clearer picture of the entire orthopedic market could develop in the next month.
How To Build A More Resilient Supply Chain Post COVID-19
Joint replacement surgeon Vinod Dasa, M.D., says there will be a heightened focus on eliminating waste and redundancies, especially in the “last mile” of the supply chain.
Studies Shed Light on Late-Onset Infection
While the spine industry has focused on 3D printed cages, enabling technology and minimally invasive surgery, it has forgotten a critical priority: infection prevention, says Aakash Agarwal, Ph.D., Director of Research at Spinal Balance.